Cellular and molecular basis for stress-induced depression

Area of Science:

• Neuroscience
• Molecular Psychiatry
• Stress Research

Background:

• Chronic stress contributes to psychiatric disorders like depression and anxiety.
• Medial prefrontal cortex (mPFC) dysfunction is implicated in stress-induced cognitive and emotional deficits.
• The specific molecular and cellular mechanisms in the mPFC underlying these disorders remain unclear.

Purpose of the Study:

• To investigate the role of the protein p11 (annexin II light chain) in stress-induced depression.
• To identify the specific neuronal populations and pathways involved in the mPFC affected by chronic stress.
• To explore p11 as a potential therapeutic target for stress-associated mental illnesses.

Main Methods:

• Chronic restraint stress model in mice.
• Analysis of p11 expression in prelimbic cortex (PrL) layer II/III neurons, specifically in dopamine D2 receptor-expressing (D2+) glutamatergic neurons.
• Behavioral assessments for depression-like phenotypes.
• Viral-mediated gene expression to manipulate p11 levels in D2+ PrL neurons.
• Electrophysiological recordings to assess glutamatergic transmission.

Main Results:

• Chronic stress selectively reduced p11 levels in layer II/III neurons of the PrL, correlating with depression-like behaviors.
• These stress-induced behavioral and molecular changes were reversed by antidepressants (SSRIs and TCAs).
• Overexpression of p11 in D2+ PrL neurons alleviated depression-like behaviors in mice with p11 deletion and restored glutamatergic transmission in stressed animals.

Conclusions:

• p11 is a critical molecular determinant in D2+ glutamatergic neurons within the PrL for regulating depression-like behaviors induced by chronic stress.
• Restoring p11 levels in these specific neurons can rescue stress-induced behavioral deficits by normalizing glutamatergic function.
• p11 represents a promising therapeutic target for developing novel treatments for stress-related psychiatric disorders.